Biote earnings were $3.2M for the trailing 12 months ending Dec 31, 2024, with -30.8% growth year over year. The latest BTMD earnings report on Dec 31, 2024 announced Q4 2024 earnings of $3.7M, down 65.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BTMD reported annual earnings of $3.2M, with -4.8% growth.
BTMD past earnings growth
How has BTMD's earnings growth performed historically?
Biote (NASDAQ: BTMD) reported Q4 2024 earnings per share (EPS) of $0.11, up 65.63% year over year. Total BTMD earnings for the quarter were $3.70 million. In the same quarter last year, Biote's earnings per share (EPS) was $0.32.
As of the last Biote earnings report, Biote is currently profitable. Biote's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $3.16 million, a 4.79% decrease year over year.
What was BTMD's earnings growth in the past year?
As of Biote's earnings date in Q2 2025, Biote's earnings has grown -30.77% year over year. This is 46.74 percentage points lower than the US Medical Care Facilities industry earnings growth rate of 15.97%. BTMD earnings in the past year totalled $3.16 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.